Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 2, 2007

Eisai Licenses Data Analysis System from Rosetta Biosoftware

  • Eisai licensed Rosetta Biosoftware’s Elucidator® system for differential protein expression analysis and biomarker discovery.

    "The Elucidator system will be an important tool for enabling quantitative methods and characterizing cancer proteomes by multidimensional LC-MS/MS," says Yoshiya Oda, Ph.D., senior scientist at the Laboratory of Seeds Finding Technology. Eisai will use the Elucidator system to help identify potential neurology biomarkers.

    According to Rosetta Biosoftware, the Elucidator system supports end-to-end data management and analysis workflow for comparative proteomics. It provides multiple ways to analyze and refine data.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »